Smith & Nephew plc files as a foreign private issuer whose SEC reports document a global medical technology business and its NYSE-traded American depositary receipts. Form 6-K reports cover trading updates, product and strategy communications, annual meeting results, dividend approvals, voting rights and capital, share buyback programs, and ordinary-share matters underlying the ADR program.
The filing record also includes disclosures on board elections, remuneration votes, treasury shares, share-plan awards under the RISE Share Plan, PDMR transactions, forward-looking statements, and business-unit performance across Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. These filings link the company’s UK corporate governance and capital structure to its U.S. reporting obligations under Form 20-F foreign-issuer status.
Smith & Nephew reported the partial vesting of conditional share awards granted under the Global Share Plan 2020. One tranche vested on 12 August 2025 from awards originally granted on 11 August 2023, which follow a three-year vesting schedule where one third vests each year.
For the disclosed individual, Rohit Kashyap (President, Advanced Wound Management and Global), 23,201 ordinary shares vested at a reported price of £13.571365. Of these, 5,670 shares were sold to cover taxation and 17,531 were retained. The transactions were executed on the London Stock Exchange for ISIN GB0009223206.
Smith & Nephew plc (SNN) has filed a Form 6-K dated 7 Aug 2025 disclosing an insider transaction under the UK Market Abuse Regulation.
- Executive: Elga Lohler, Chief HR Officer (classified as a PDMR).
- Action: Sale of ordinary shares.
- Volume: 12,559.65422 shares.
- Price: £13.407957 per share.
- Gross proceeds: ≈ £168 k.
- Venue: London Stock Exchange (XLON).
- ISIN: GB0009223206.
No financial results, guidance changes or strategic announcements accompany the filing. The disclosure appears administrative, fulfilling regulatory obligations, but investors may monitor future insider activity for sentiment cues.
On 11 July 2025, Smith & Nephew plc filed a Form 6-K reporting insider share purchases carried out on 9 July 2025 under the Company’s Employee Stock Purchase Plan (ESPP). Chief Executive Officer Deepak Nath and four other persons discharging managerial responsibilities (PDMRs) bought American Depositary Shares (ADSs) on the New York Stock Exchange at a uniform price of US$29.77358 per ADS.
Individual purchases were: Nath and Paul Connolly, each 512.29508 ADSs; Craig Gaffin, 381.29219 ADSs; Scott Schaffner, 298.19045 ADSs; and Mizanu Kebede, 114.62247 ADSs. The combined volume equals roughly 1,819 ADSs, an aggregate consideration of about US$54,000. The disclosure was made in accordance with the UK Market Abuse Regulation; no additional financial metrics, guidance or strategic updates accompanied the filing.
While routine and modest in value, the insider buying may be interpreted as a limited vote of confidence by senior management. However, because the transactions occurred through a scheduled ESPP and represent a small fraction of daily trading volume, their market impact is expected to be minimal.